Companies: 10,795·Total market cap: $144.5T

Polyrizon Ltd.

Polyrizon Ltd.

PLRZNASDAQHealthcare● Active

$12.52

$-0.47(-3.62%)

Market Cap$14025029

P/E Ratio—

52W High$18.2

52W Low$2.88

Avg Volume42K

Open$12.47

Beta-1.84

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Polyrizon Ltd.（PLRZ）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PLRZ · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-38.38Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding1.6MShares outstanding history

Next EarningsTBAEarnings history

探索 Polyrizon Ltd. 数据

分析师预测—

股息不分红

盈利EPS $-2.07+98.46%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$3.3M▼ 115.86% YoY

202320242025

FY 2025EPS$-2.07▲ +98.46% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$4.1MEPS: $-38.38View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$12.52-3.62%$14.0M #2

AIM ImmunoTech Inc.

$0.52+0.60%$1.8M #3

Cyclerion Therapeutics, Inc.

$3.01+1.01%$13.0M #4

Pasithea Therapeutics Corp.

$0.58-1.61%$4.3M #5

NovaBay Pharmaceuticals, Inc.

$1.47-24.62%$39.1M #6

PharmaCyte Biotech, Inc.

$0.70+0.00%$4.8M

股票表现

1D-3.62%

1W-11.21%

1M-23.38%

3M-4.50%

YTD+47.47%

1Y+149.40%

5Y-99.46%

关于 Polyrizon Ltd.

CEOTomer Izraeli

IPO DateOct 29, 2024

Employees2

CountryIL

Websitepolyrizon-biotech.com

Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier w…

Biotechnology HealthcareNASDAQIL

关于股票概览与关键数据

Polyrizon Ltd.（PLRZ）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 29, 2024 在 NASDAQ 上市。截至最近交易日，PLRZ 股价为 $12.52，市值约为 $14.0M。过去12个月累计回报 +149.40%，年初至今回报 +47.47%。

2025 财年 Polyrizon Ltd. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Polyrizon Ltd.（PLRZ）股价为 $12.52，在 NASDAQ 上市，52周区间为 $2.88 – $18.20。

PLRZ 最新股价PLRZ quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议